Comparison of Efficacy of Antiseptic DROPsept and Antibiotic Tobrex in Patients with Chronic Blepharitis
Authors:
Eliška Hrůzová 1,2
Authors‘ workplace:
Lexum Eye Clinic, Brno, Czech Republic
1; Private Ophthalmology Practice, Hrušovany nad Jevišovkou, Czech Republic
2
Published in:
Čes. a slov. Oftal., 82, 2026, No. Ahead of Print, p. 1-7
Category:
Original Article
doi:
https://doi.org/10.31348/2026/37
Overview
Aim: To compare the efficacy and safety of DROPsept antiseptic eye drops (chlorhexidine digluconate 0.02% + Vitamin E TPGS 0.2%) with Tobrex antibiotic eye drops (tobramycin 0.3%) in patients with chronic blepharitis. Material and Methods: Forty patients with chronic blepharitis were included in this prospective clinical evaluation (Tobrex group n = 20, DROPsept group n = 20), treated 4 times daily for 1 week, followed by application of preservative-free artificial tears. All patients received instructions on eyelid hygiene, warm compresses and Meibomian gland massage. Assessment was performed at T0 (baseline), T1 (1 week) and T2 (1 month). The evaluated parameters included BSS score (Blepharitis Severity Score) (0–12), microbiological swabs and a subjective questionnaire. Results: Baseline BSS scores were comparable (Tobrex 5.55 ±1.83; DROPsept 5.80 ±1.57). After 1 week, the BSS score was significantly lower in the DROPsept group (2.86 ±1.49 vs. 4.20 ±2.09; p = 0.033). At T2, the favorable trend persisted in the DROPsept group (2.22 ±1.93 vs. 2.67 ±2.33; p = 0.689). In patients with an initially positive microbiological culture result, after a week of treatment the result was negative in 73% of patients receiving DROPsept therapy and in 57% of patients receiving Tobrex therapy. Patient satisfaction was significantly higher in the DROPsept group (9.2 ±1.4 vs. 6.6 ±2.8; p = 0.013). Conclusion: DROPsept demonstrated a faster reduction of the BSS score after 1 week (p = 0.033) and significantly higher patient satisfaction (p = 0.013). The numerically higher eradication rate (73% vs. 57%) did not reach the level of statistical significance (p = 0.627). DROPsept offers the advantage of no risk of antibiotic resistance and a favorable safety profile. These findings are exploratory; confirmation in a larger randomized controlled trial with placebo control is required.
Keywords:
Antibiotic resistance – Cataract surgery – blepharitis – chlorhexidine – antiseptic – DROPsept – tobramycin – Meibomian glands
Labels
OphthalmologyArticle was published in
Czech and Slovak Ophthalmology
2026 Issue Ahead of Print
-
All articles in this issue
- Progresivní keratokonus jako komplikace atopické keratokonjunktivitidy. Kazuistika
- Trifocal Versus Monofocal Intraocular Lenses: A Prospective Assessment of Visual Outcomes and Patient-Reported Satisfaction
- Diagnostic and Potentially Prognostic Value of Novel Inflammatory Indices in Non-Arteritic Anterior Ischemic Optic Neuropathy
- Okluze centrální retinální arterie – naše budoucí cesta k zavedení intravenózní trombolýzy
- Two-year Outcomes of Combined Gonioscopy-Assisted Transluminal Trabeculotomy and Cataract Extraction in Ocular Hypertension and Primary Open-Angle Glaucoma
- Retinitis pigmentosa sine pigmento maskovaná ako normotenzný glaukóm. Kazuistika
- Dlouhodobé výsledky chirurgické léčby jednostranného primárního kongenitálního a infantilního glaukomu
- Cholesterolóza přední komory u ročního dítěte s Coatsovou chorobou. Kazuistika
- Outcomes of Post-Traumatic Pediatric Endophthalmitis Following 25-Gauge Pars Plana Vitrectomy
- Clinical Features and Therapeutic Alternatives in Eyes with Secondary Vasoproliferative Tumors: A Single-Center Turkish Perspective
- Association of Aqueous Humor Tumor Necrosis Factor Alpha with Retinal Ganglion Cell Thickness in Juvenile versus Adult-Onset Primary Open-Angle Glaucoma
- Evaluation of AI Citation Accuracy in Anterior Segment Research
- Histomorphological Changes in Experimental Autoimmune Uveitis of Varying Severity
- Treatment of Ametropic Amblyopia and the Significance of Cycloplegia in Childhood
- Intravitreal Steroid and Anti-VEGF in Macular Edema Secondary to Retinal Vein Occlusion
- Mirvetuximab Soravtansine and its TreatmentAssociated Ocular Adverse Effects. A Review of the Current Knowledge
- Preserflo MicroShunt – A Modern Microinvasive Approach in the Surgical Treatment of Glaucoma. A Review
- Comparison of Safety and Efficacy of Two Dispersive Hyaluronate OVDs Used in Cataract Surgery
- iStent Inject Implantation for Pseudoexfoliative Glaucoma. A Scoping Review
- Assessment of the Relationship between Metabolic Activity of Uveal Melanoma in Positron Emission Tomography (PET) and Chromosome 3 Monosomy
- Optical Coherence Tomography Angiography Findings in Patients with New-Onset Type 2 Diabetes and No Signs of Diabetic Retinopathy
- Comparison of Efficacy of Antiseptic DROPsept and Antibiotic Tobrex in Patients with Chronic Blepharitis
- Giant Cell Arteritis in Ophthalmology – Current Treatment Options. A Review
- Idiopathic Macular Hole Surgery without Intraocular Gas Tamponade: Surgical Technique, Biological Rationale, and Initial Clinical Experience
- Clinical Profile and Surgical Outcomes in Brown Syndrome – A Retrospective Case Series
- Czech and Slovak Ophthalmology
- Journal archive
- Current issue
- Online only
- About the journal
Most read in this issue
- Progresivní keratokonus jako komplikace atopické keratokonjunktivitidy. Kazuistika
- Okluze centrální retinální arterie – naše budoucí cesta k zavedení intravenózní trombolýzy
- Trifocal Versus Monofocal Intraocular Lenses: A Prospective Assessment of Visual Outcomes and Patient-Reported Satisfaction
- Diagnostic and Potentially Prognostic Value of Novel Inflammatory Indices in Non-Arteritic Anterior Ischemic Optic Neuropathy